The Ever-Changing Hard Surface Disinfectant Landscape in COVID-19 times

The Ever-Changing Hard Surface Disinfectant Landscape in COVID-19 times

Published on April 14, 2020

Author: Teri Dickinson, Manager, Regulatory Affairs, Dell Tech Laboratories Ltd.

These days, the world of hard surface disinfectants and pathway to registration changes almost weekly.  With the health and safety of Canadians being at the fore front the quick access to disinfectant products has been a top priority. 

Health Canada has implemented interim measures to expedite access to disinfectants to address product shortages and published a list of hard-surface disinfectants that are likely to be effective for use against coronavirus (COVID-19).

Want your product to be on the list?  Want to make indirect efficacy claims for SARS-CoV-2, the virus that causes COVID-19? Your product will need to be reviewed and approved with one or more of the following:

  • labelled as a broad-spectrum virucide, that is supported by an efficacy claim against any of:
    •    Adenovirus type 5
    •    Bovine Parovirus
    •    Canine Parvovirus
    •    Poliovirus type 1
  • carry a specific claim against non-enveloped viruses of the picornaviridae, caliciviridae, astroviridae, reoviridae, or papillomaviridae families or
  • carry a specific claim against a specific coronavirus, such as
    •    MERS-CoV
    •    SARS-CoV
    •    human coronavirus strain 229E

References:

Hard-surface disinfectants and hand sanitizers (COVID-19): List of hard-surface disinfectants 

https://www.canada.ca/en/health-canada/services/drugs-health-products/disinfectants/covid-19/list.html

 

 

Related Articles

Health Canada’s Proposal for Clinical Trials Regulatory Modernization

Health Canada’s Proposal for Clinical Trials Regulatory Modernization

On May 20, 2021 Health Canada opened a consultation on its proposal to modernize the regulatory framework for clinical trials related to human drugs, medical devices,...

Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19

Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19

In response to the ongoing need for innovative COVID-19 diagnosis, treatment, mitigation, or prevention options, Health Canada announced the approval of Interim Order No. 2...